These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17574124)

  • 1. From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization.
    Hellings WE; Peeters W; Moll FL; Pasterkamp G
    Trends Cardiovasc Med; 2007 Jul; 17(5):162-71. PubMed ID: 17574124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease.
    Hurks R; Peeters W; Derksen WJ; Hellings WE; Hoefer IE; Moll FL; de Kleijn DP; Pasterkamp G
    Thromb Haemost; 2009 Jan; 101(1):48-54. PubMed ID: 19132188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
    Naghavi M; Libby P; Falk E; Casscells SW; Litovsky S; Rumberger J; Badimon JJ; Stefanadis C; Moreno P; Pasterkamp G; Fayad Z; Stone PH; Waxman S; Raggi P; Madjid M; Zarrabi A; Burke A; Yuan C; Fitzgerald PJ; Siscovick DS; de Korte CL; Aikawa M; Juhani Airaksinen KE; Assmann G; Becker CR; Chesebro JH; Farb A; Galis ZS; Jackson C; Jang IK; Koenig W; Lodder RA; March K; Demirovic J; Navab M; Priori SG; Rekhter MD; Bahr R; Grundy SM; Mehran R; Colombo A; Boerwinkle E; Ballantyne C; Insull W; Schwartz RS; Vogel R; Serruys PW; Hansson GK; Faxon DP; Kaul S; Drexler H; Greenland P; Muller JE; Virmani R; Ridker PM; Zipes DP; Shah PK; Willerson JT
    Circulation; 2003 Oct; 108(14):1664-72. PubMed ID: 14530185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
    Naghavi M; Libby P; Falk E; Casscells SW; Litovsky S; Rumberger J; Badimon JJ; Stefanadis C; Moreno P; Pasterkamp G; Fayad Z; Stone PH; Waxman S; Raggi P; Madjid M; Zarrabi A; Burke A; Yuan C; Fitzgerald PJ; Siscovick DS; de Korte CL; Aikawa M; Airaksinen KE; Assmann G; Becker CR; Chesebro JH; Farb A; Galis ZS; Jackson C; Jang IK; Koenig W; Lodder RA; March K; Demirovic J; Navab M; Priori SG; Rekhter MD; Bahr R; Grundy SM; Mehran R; Colombo A; Boerwinkle E; Ballantyne C; Insull W; Schwartz RS; Vogel R; Serruys PW; Hansson GK; Faxon DP; Kaul S; Drexler H; Greenland P; Muller JE; Virmani R; Ridker PM; Zipes DP; Shah PK; Willerson JT
    Circulation; 2003 Oct; 108(15):1772-8. PubMed ID: 14557340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M; Falk E; Hecht HS; Jamieson MJ; Kaul S; Berman D; Fayad Z; Budoff MJ; Rumberger J; Naqvi TZ; Shaw LJ; Faergeman O; Cohn J; Bahr R; Koenig W; Demirovic J; Arking D; Herrera VL; Badimon J; Goldstein JA; Rudy Y; Airaksinen J; Schwartz RS; Riley WA; Mendes RA; Douglas P; Shah PK;
    Am J Cardiol; 2006 Jul; 98(2A):2H-15H. PubMed ID: 16843744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vulnerable patient: refocusing on the plaque?
    Eijgelaar WJ; Heeneman S; Daemen MJ
    Thromb Haemost; 2009 Aug; 102(2):231-9. PubMed ID: 19652873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finding vulnerable atherosclerotic plaques: is it worth the effort?
    Madjid M; Zarrabi A; Litovsky S; Willerson JT; Casscells W
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1775-82. PubMed ID: 15308556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events.
    Peeters W; de Kleijn DP; Vink A; van de Weg S; Schoneveld AH; Sze SK; van der Spek PJ; de Vries JP; Moll FL; Pasterkamp G
    Eur Heart J; 2011 Jul; 32(14):1758-68. PubMed ID: 21059735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In search of the "vulnerable plaque": can it be localized and will focal regional therapy ever be an option for cardiac prevention?
    Ambrose JA
    J Am Coll Cardiol; 2008 Apr; 51(16):1539-42. PubMed ID: 18420095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying the vulnerable patient with rupture-prone plaque.
    Weintraub HS
    Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quest for novel cardiovascular biomarkers by proteomic analysis.
    Vivanco F; Martín-Ventura JL; Duran MC; Barderas MG; Blanco-Colio L; Dardé VM; Mas S; Meilhac O; Michel JB; Tuñón J; Egido J
    J Proteome Res; 2005; 4(4):1181-91. PubMed ID: 16083268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods.
    Saia F; Schaar J; Regar E; Rodriguez G; De Feyter PJ; Mastik F; Marzocchi A; Marrozzini C; Ortolani P; Palmerini T; Branzi A; van der Steen AF; Serruys PW
    J Cardiovasc Med (Hagerstown); 2006 Jan; 7(1):21-8. PubMed ID: 16645356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From carotid plaque biology to serologic markers of vulnerability to predict the risk of cerebrovascular events.
    Cola C; Clementi E; Biondi-Zoccai G; Sangiorgi G
    Acta Chir Belg; 2007; 107(2):129-42. PubMed ID: 17515260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerotic plaque rupture: local or systemic process?
    Lutgens E; van Suylen RJ; Faber BC; Gijbels MJ; Eurlings PM; Bijnens AP; Cleutjens KB; Heeneman S; Daemen MJ
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2123-30. PubMed ID: 14512372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The vulnerable plaque: a necessary concept in the management of atherothrombosis].
    Rioufol G; Finet G
    Arch Mal Coeur Vaiss; 2002 Dec; 95(12):1210-4. PubMed ID: 12611042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and treatment of vulnerable plaque.
    Nakamura M; Lee DP; Yeung AC
    Rev Cardiovasc Med; 2004; 5 Suppl 2():S22-33. PubMed ID: 15184831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection and treatment of vulnerable plaque].
    Gaxiola E
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-178-84. PubMed ID: 18938723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of inflammation in atherosclerosis.
    Spagnoli LG; Bonanno E; Sangiorgi G; Mauriello A
    J Nucl Med; 2007 Nov; 48(11):1800-15. PubMed ID: 17942804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New predictors of adverse cardiovascular events following vascular surgery.
    van Lammeren GW; de Vries JP; Vink A; de Kleijn DP; Moll FL; Pasterkamp G
    Semin Cardiothorac Vasc Anesth; 2010 Jun; 14(2):148-53. PubMed ID: 20478956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.